2013
DOI: 10.1016/j.rvsc.2012.09.025
|View full text |Cite
|
Sign up to set email alerts
|

Relevance of feline interferon omega for clinical improvement and reduction of concurrent viral excretion in retrovirus infected cats from a rescue shelter

Abstract: Feline Immnunodeficiency (FIV) and Feline Leukemia (FeLV) viruses are common infectious agents in stray cats and shelter environments. Recombinant feline interferon-ω (rFeIFNω) has shown an antiviral action not only against FIV and FeLV but also against herpesvirus (FHV-1) and calicivirus (FCV). Sixteen naturally infected FIV/FeLV cats were followed during rFeIFNω therapy in order to monitor clinical signs and to correlate with excretion of concomitant viruses (FCV, FHV-1, feline coronavirus (FCoV) and parvovi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

9
66
0
9

Year Published

2015
2015
2025
2025

Publication Types

Select...
4
3
1

Relationship

0
8

Authors

Journals

citations
Cited by 45 publications
(84 citation statements)
references
References 37 publications
9
66
0
9
Order By: Relevance
“…119 In another study evaluating naturally FIV-infected cats housed in a shelter, some clinical improvement was seen with IFN-ω treatment administered at the above-mentioned high dose, but in this study there was no placebo control. 106 Haematological values remained within reference intervals, and there were no biochemical abnormalities asso ciated with IFN-ω treatment (EBM grade III).…”
Section: Conflict Of Interestmentioning
confidence: 81%
See 2 more Smart Citations
“…119 In another study evaluating naturally FIV-infected cats housed in a shelter, some clinical improvement was seen with IFN-ω treatment administered at the above-mentioned high dose, but in this study there was no placebo control. 106 Haematological values remained within reference intervals, and there were no biochemical abnormalities asso ciated with IFN-ω treatment (EBM grade III).…”
Section: Conflict Of Interestmentioning
confidence: 81%
“…In another study evaluating FeLV-infected cats housed in a shelter, some clinical improvement was noted with IFN-ω treatment using the same dose as described above, but no placebo group was included, precluding a definitive assessment (EBM grade III). 106 No studies have been published so far on the oral use of IFN-ω in FeLV-infected cats.…”
Section: Conflict Of Interestmentioning
confidence: 99%
See 1 more Smart Citation
“…Він навіть одержав неофіційну назву «котячо-го». Клінічна ефективність інтерферону омега у котів була показана при лікуванні захворювань спричинених вірусами лейкемії котів та котячого імунодефіциту [23,29], а також вірусами герпе-су та каліцивірусу [41]. Крім цього, інтерферон омега з успіхом був застосований і для лікуван-ня захворювань собак, зокрема, парвовірусного ентериту [22] та атопічного дерматиту [67].…”
Section: The Information About the Use Of Interferons In Veterinary Munclassified
“…5 Diagnostic FHV-1 viral inclusion bodies are seen within the intact epithelium but may not be present when samples are collected from only areas of ulceration. [11][12][13] One study 14 examining the efficacy of valacyclovir was similarly unrewarding and actually resulted in toxic effects in the treated cats with early termination of the study for humane reasons. 1 Treatment of FHV-1 infection in cats is challenging and is often limited to supportive care and treatment of secondary infections.…”
Section: Commentsmentioning
confidence: 99%